Literature DB >> 31914635

Hepatocyte p53 ablation induces metabolic dysregulation that is corrected by food restriction and vertical sleeve gastrectomy in mice.

Marlena M Holter1, Darline Garibay1, Seon A Lee1, Mridusmita Saikia1, Anne K McGavigan1, Lily Ngyuen2, Elizabeth S Moore1, Erin Daugherity1, Paul Cohen2, Kathleen Kelly1, Robert S Weiss1, Bethany P Cummings1.   

Abstract

P53 has been implicated in the pathogenesis of obesity and diabetes; however, the mechanisms and tissue sites of action are incompletely defined. Therefore, we investigated the role of hepatocyte p53 in metabolic homeostasis using a hepatocyte-specific p53 knockout mouse model. To gain further mechanistic insight, we studied mice under two complementary conditions of restricted weight gain: vertical sleeve gastrectomy (VSG) or food restriction. VSG or sham surgery was performed in high-fat diet-fed male hepatocyte-specific p53 wild-type and knockout littermates. Sham-operated mice were fed ad libitum or food restricted to match their body weight to VSG-operated mice. Hepatocyte-specific p53 ablation in sham-operated ad libitum-fed mice impaired glucose homeostasis, increased body weight, and decreased energy expenditure without changing food intake. The metabolic deficits induced by hepatocyte-specific p53 ablation were corrected, in part by food restriction, and completely by VSG. Unlike food restriction, VSG corrected the effect of hepatocyte p53 ablation to lower energy expenditure, resulting in a greater improvement in glucose homeostasis compared with food restricted mice. These data reveal an important new role for hepatocyte p53 in the regulation of energy expenditure and body weight and suggest that VSG can improve alterations in energetics associated with p53 dysregulation.
© 2019 Federation of American Societies for Experimental Biology.

Entities:  

Keywords:  bariatric surgery; body weight; energy expenditure; p53

Mesh:

Substances:

Year:  2019        PMID: 31914635      PMCID: PMC8884714          DOI: 10.1096/fj.201902214R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  46 in total

1.  Identification of transcriptional networks during liver regeneration.

Authors:  Peter White; John E Brestelli; Klaus H Kaestner; Linda E Greenbaum
Journal:  J Biol Chem       Date:  2004-11-16       Impact factor: 5.157

Review 2.  Brown adipose tissue--a new role in humans?

Authors:  Martin E Lidell; Sven Enerbäck
Journal:  Nat Rev Endocrinol       Date:  2010-04-13       Impact factor: 43.330

3.  Gene expression profiling of the PPAR-alpha agonist ciprofibrate in the cynomolgus monkey liver.

Authors:  Neal F Cariello; Elizabeth H Romach; Heidi M Colton; Hong Ni; Lawrence Yoon; J Greg Falls; Warren Casey; Donald Creech; Steven P Anderson; Gina R Benavides; Debie J Hoivik; Roger Brown; Richard T Miller
Journal:  Toxicol Sci       Date:  2005-08-04       Impact factor: 4.849

4.  Body Composition, Food Intake, and Energy Expenditure in a Murine Model of Roux-en-Y Gastric Bypass Surgery.

Authors:  Zheng Hao; Michael B Mumphrey; R Leigh Townsend; Christopher D Morrison; Heike Münzberg; Jianping Ye; Hans-Rudolf Berthoud
Journal:  Obes Surg       Date:  2016-09       Impact factor: 4.129

5.  p53 is required for brown adipogenic differentiation and has a protective role against diet-induced obesity.

Authors:  A Molchadsky; O Ezra; P G Amendola; D Krantz; I Kogan-Sakin; Y Buganim; N Rivlin; N Goldfinger; V Folgiero; R Falcioni; R Sarig; V Rotter
Journal:  Cell Death Differ       Date:  2013-02-15       Impact factor: 15.828

6.  Impaired skeletal muscle mitochondrial function in morbidly obese patients is normalized one year after bariatric surgery.

Authors:  Guy H E J Vijgen; Nicole D Bouvy; Joris Hoeks; Sander Wijers; Patrick Schrauwen; Wouter D van Marken Lichtenbelt
Journal:  Surg Obes Relat Dis       Date:  2013-04-18       Impact factor: 4.734

7.  p53 regulates expression of uncoupling protein 1 through binding and repression of PPARγ coactivator-1α.

Authors:  Philip Hallenborg; Even Fjære; Bjørn Liaset; Rasmus Koefoed Petersen; Incoronata Murano; Si Brask Sonne; Mathias Falkerslev; Sally Winther; Benjamin Anderschou Holbech Jensen; Tao Ma; Jacob B Hansen; Saverio Cinti; Blagoy Blagoev; Lise Madsen; Karsten Kristiansen
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-11-17       Impact factor: 4.310

8.  p53 improves aerobic exercise capacity and augments skeletal muscle mitochondrial DNA content.

Authors:  Joon-Young Park; Ping-Yuan Wang; Takumi Matsumoto; Ho Joong Sung; Wenzhe Ma; Jeong W Choi; Stasia A Anderson; Scot C Leary; Robert S Balaban; Ju-Gyeong Kang; Paul M Hwang
Journal:  Circ Res       Date:  2009-08-20       Impact factor: 17.367

Review 9.  Bariatric surgery: a systematic review and meta-analysis.

Authors:  Henry Buchwald; Yoav Avidor; Eugene Braunwald; Michael D Jensen; Walter Pories; Kyle Fahrbach; Karen Schoelles
Journal:  JAMA       Date:  2004-10-13       Impact factor: 56.272

10.  Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus.

Authors:  W J Pories; M S Swanson; K G MacDonald; S B Long; P G Morris; B M Brown; H A Barakat; R A deRamon; G Israel; J M Dolezal
Journal:  Ann Surg       Date:  1995-09       Impact factor: 12.969

View more
  3 in total

1.  Diet-dependent sex differences in the response to vertical sleeve gastrectomy.

Authors:  Chelsea R Hutch; Daria Stelmak; Matt Kanke; Kieran Koch-Laskowski; Bethany Cummings; Cameron Griffin; Kyle Leix; Praveen Sethupathy; Kanakadurga Singer; Darleen A Sandoval
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-05-17       Impact factor: 5.900

2.  Hyperuricemia Predisposes to the Onset of Diabetes via Promoting Pancreatic β-Cell Death in Uricase-Deficient Male Mice.

Authors:  Jie Lu; Yuwei He; Lingling Cui; Xiaoming Xing; Zhen Liu; Xinde Li; Hui Zhang; Hailong Li; Wenyan Sun; Aichang Ji; Yao Wang; Huiyong Yin; Changgui Li
Journal:  Diabetes       Date:  2020-04-20       Impact factor: 9.461

3.  Hepatic MDM2 Causes Metabolic Associated Fatty Liver Disease by Blocking Triglyceride-VLDL Secretion via ApoB Degradation.

Authors:  Huige Lin; Lin Wang; Zhuohao Liu; Kekao Long; Mengjie Kong; Dewei Ye; Xi Chen; Kai Wang; Kelvin Kl Wu; Mengqi Fan; Erfei Song; Cunchuan Wang; Ruby Lc Hoo; Xiaoyan Hui; Philip Hallenborg; Hailong Piao; Aimin Xu; Kenneth Ky Cheng
Journal:  Adv Sci (Weinh)       Date:  2022-05-07       Impact factor: 17.521

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.